Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Larsson-Cohn

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Lakartidningen|June 15, 1970
[Peroral contraception (5): continuing low dosage treatment]U Larsson-Cohn
Acta Endocrinologica|November 1, 1977
Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. I. Glucose, insulin and human growth hormone levels during oral glucose tolerance testsU Larsson-Cohn, L Wallentin
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1978
Massive enlargement of occluded tubes after postmenopausal treatment with natural estrogensM Hammar, U Larsson-Cohn
Fertility and Sterility|November 1, 1982
Estrogen and menopauseU Larsson-Cohn, L Wallentin
Lancet (London, England)|June 25, 1977
Postmenopausal oestrogen replacement and lipidsL Wallentin, U Larsson-Cohn
Acta Endocrinologica|December 1, 1982
Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17 beta to menopausal womenL Fåhraeus, U Larsson-Cohn
Lakartidningen|March 7, 1979
[Estrogen-gestagen and HDL-cholesterol]U Larsson-Cohn, L Wallentin
Lakartidningen|June 15, 1970
[Peroral contraception (9): use of oral contraceptives in Sweden in 1969]U Larsson-Cohn, J Trost
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1977
Lipids during postmenopausal treatment with estradiol valerianate and ethinyl estradiol-preliminary communicationL Wallentin, U Larsson-Cohn
Acta Endocrinologica|November 1, 1977
Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipidsL Wallentin, U Larsson-Cohn
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Lakartidningen|June 15, 1970
[Peroral contraception (5): continuing low dosage treatment]U Larsson-Cohn
Acta Endocrinologica|November 1, 1977
Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. I. Glucose, insulin and human growth hormone levels during oral glucose tolerance testsU Larsson-Cohn, L Wallentin
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1978
Massive enlargement of occluded tubes after postmenopausal treatment with natural estrogensM Hammar, U Larsson-Cohn
Fertility and Sterility|November 1, 1982
Estrogen and menopauseU Larsson-Cohn, L Wallentin
Lancet (London, England)|June 25, 1977
Postmenopausal oestrogen replacement and lipidsL Wallentin, U Larsson-Cohn
Acta Endocrinologica|December 1, 1982
Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17 beta to menopausal womenL Fåhraeus, U Larsson-Cohn
Lakartidningen|March 7, 1979
[Estrogen-gestagen and HDL-cholesterol]U Larsson-Cohn, L Wallentin
Lakartidningen|June 15, 1970
[Peroral contraception (9): use of oral contraceptives in Sweden in 1969]U Larsson-Cohn, J Trost
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1977
Lipids during postmenopausal treatment with estradiol valerianate and ethinyl estradiol-preliminary communicationL Wallentin, U Larsson-Cohn
Acta Endocrinologica|November 1, 1977
Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipidsL Wallentin, U Larsson-Cohn
Pageof 6